Adam Savitz

Adam Savitz

Direttore Tecnico/Scientifico/R&S presso ALTO NEUROSCIENCE, INC.

Patrimonio netto: 351 145 $ in data 30/04/2024

59 anni
Consumer Services
Health Technology
Commercial Services

Provenienza dei contatti di primo grado di Adam Savitz

EntitàTipo di entitàSettore Industriale
Public Company Biotechnology 17
10
Subsidiary Miscellaneous Commercial Services 10

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Adam Savitz tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
JOHNSON & JOHNSON Pharmaceuticals: Major

Mathai Mammen

William Hait

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Investment Banks/Brokers

Po Yu Chen

Analyst-Equity

AC IMMUNE SA Pharmaceuticals: Major

Roy Ervin Twyman

Director/Board Member

MEAD JOHNSON NUTRITION CO Food: Meat/Fish/Dairy

Erin McQuade

Melissa Berman

Compliance Officer

Investor Relations Contact

Packaged Software

Roy Ervin Twyman

Director/Board Member

MORPHOSYS AG Biotechnology

Robert Friesen

Corporate Officer/Principal

Investment Managers

Po Yu Chen

Analyst-Equity

Boston University College/University

Thomas Insel

Doctorate Degree

Emory University College/University

Thomas Insel

Corporate Officer/Principal

PHARMING GROUP N.V. Pharmaceuticals: Major

Robert Friesen

Chief Tech/Sci/R&D Officer

Massachusetts Institute of Technology College/University

Mathai Mammen

Amit Etkin

Doctorate Degree

Undergraduate Degree

Central Michigan University College/University

William Strohl

Undergraduate Degree

State of California Province/State

Thomas Insel

Consultant / Advisor

The University of Texas at Austin College/University

Robert Friesen

Doctorate Degree

The Johns Hopkins University College/University

Chris Dimitropoulos

Po Yu Chen

Graduate Degree

Doctorate Degree

Louisiana State University College/University

William Strohl

Doctorate Degree

College/University

William Strohl

Corporate Officer/Principal

The Pennsylvania State University College/University

Po Yu Chen

Undergraduate Degree

University of Kentucky College/University

Roy Ervin Twyman

Undergraduate Degree

ABLYNX Biotechnology

Robert Friesen

Chief Tech/Sci/R&D Officer

University of Utrecht College/University

Robert Friesen

Graduate Degree

National Institute of Mental Health General Government

Thomas Insel

Director/Board Member

HYATT HOTELS CORPORATION Hotels/Resorts/Cruise lines

Erin McQuade

Melissa Berman

Compliance Officer

Corporate Officer/Principal

National Academy of Medicine

Thomas Insel

Corporate Officer/Principal

Biotechnology

Erin McQuade

Melissa Berman

General Counsel

Director of Finance/CFO

Janssen Biotherapeutics

William Strohl

Robert Friesen

Corporate Officer/Principal

Corporate Officer/Principal

Center For Behavioral Neuroscience

Thomas Insel

Director/Board Member

Steinberg Institute

Thomas Insel

Chairman

Internet Software/Services

Thomas Insel

Consultant / Advisor

COMPASS PATHWAYS PLC Biotechnology

Thomas Insel

Consultant / Advisor

National Agency

Thomas Insel

Director/Board Member

Investment Managers

Thomas Insel

Consultant / Advisor

PROQR THERAPEUTICS N.V. Pharmaceuticals: Major

Robert Friesen

Corporate Officer/Principal

IGM BIOSCIENCES, INC. Pharmaceuticals: Major

William Strohl

Director/Board Member

BiStro Biotech Consulting LLC

William Strohl

Founder

Cortical Capital LLC

Thomas Insel

Founder

HEAE CAPI Financial Conglomerates

Thomas Insel

Director/Board Member

Medical/Nursing Services

Thomas Insel

Founder

Amron Neuroscience LLC

Roy Ervin Twyman

Chief Executive Officer

Statistiche

Distribuzione geografica

Stati Uniti 33
Paesi Bassi 5
Belgio 3
Svizzera 2
Germania 2

Settori

Health Technology 12
Consumer Services 12
Finance 6
Technology Services 5
Government 4

Posizioni

Director/Board Member 66
Corporate Officer/Principal 51
Undergraduate Degree 23
Chief Tech/Sci/R&D Officer 20
Doctorate Degree 17
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA